Number and distribution of pelvic lymph nodes and effect of surgical pathologic factors on pelvic lymph node status in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection

Purpose of investigation: To report the number and distribution of pelvic lymph nodes and to identify surgical pathologic factors that best predict positive pelvic lymph nodes in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection (RHND).

Methods: Data from the files of 126 patients with cervical carcinoma treated by RHND at the Soroka Medical Center from 1962 through 2005 were analyzed.

Results: The status of pelvic lymph nodes was known in 114 patients. The exact number of lymph nodes removed from the pelvis of each patient was known in 111 patients. The mean number of lymph nodes removed from the pelvis per patient was 26.6 (median 23; range 1-62). Positive pelvic lymph nodes were found in 35 (30.7%) of the patients with a mean of 3.4 (median 2; range, 1-15) positive pelvic lymph nodes per patient. In a univariate analysis, positive lymph vascular space invasion and positive parametrial and/or paracervical involvement were significant predictors of positive pelvic lymph nodes, whereas penetration > or = 50% of the thickness of the cervical wall and grade 2+3 were of borderline significance. In a multivariate analysis, positive lymph vascular space invasion was the strongest and the only significant predictor of positive pelvic lymph nodes, whereas positive parametrial and/or paracervical involvement was of borderline significance.

Conclusions: In patients with early-stage cervical carcinoma treated with RHND, positive lymph vascular space invasion emerged to be the strongest and most significant predictor of positive pelvic lymph nodes.

Cervical carcinoma; Lymph nodes; Prognostic factors; Lymph vascular space invasion

[1] Monk B.J., Cha D-S., Walker J.L., Burger R.A., Ramsingham N.S., Manetta A. et al.: "Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of Stage 1B and IIA cervical carcinoma". Gynecol. Oneal., 1994, 54, 4.

[2] Smiley L.M., Burke T.W., S仆va E.G., Morris M., Gershenson D.M.,W harton J.T.: "Prognostic factors in Stage 1B squamous cervical cancer patients with low risk for recurrence". Obstet Gynecol., 1991, 77, 271.

[3] Piura B., Rabinovich A., Friger M.: "Surgical pathologic factors rn patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection: association with administration of adjuvant radiotherapy and effect on survival". Eur. J. Gynaecol. Oneal., 2006, 5, 1127.

[4] Shinohara S., Ochi T., Miyazaki T., Fujii T., Kawamura M., Mochizuki T., Ito M.: "Histopathological prognostic factors in patients with cervical cancer treated with radical hysterectomy and postoperative radiotherapy". Int. J. Clin. Oneal., 2004, 9, 503.

[5] Kim J.H., Kim H.J., Hong S., Wu H-G., Ha S.W.: "Post-hysterectomy radiotherapy in FIGO Stage IB-IIB uterine cervical carcinoma". Gynecol. Oneal., 2005, 96, 407.

[6] Van de Putte G., Lie A.K., Yach W., Baekelandt M., Kristensen G.B.: "Risk grouping in stage 1B squamous cell cervical carcinoma". Gynecol. Oncol., 2005, 99, 106.

[7] Piver M.S., Rutledge F.N., Smith P.J.: "Five classes of extended hysterectomy for women with cervical cancer". Obstet. Gynecol., 1974, 44, 265.

[8] Shepherd J.H.: "Revised FIGO staging for gynaecological cancer" Br. J. Obstet. Gynaecol., 1989, 96, 889.

[9] Swinscow T.D.V.: "Statistics at Square One". Tavistock Square, London, British Medical Association, 1983.

[10] Morrison D.F.: "Multivariate statistical methods." New York, McGraw-Hill, 1990.

[11] Burghardt E.: "Cervical cancer". In: Burghardt E., Webb M.J., Monaghan J.M., Kindermann G. (eds). "Surgical Gynecologic Oncology". New York, Georg Thieme Verlag Stuttgart, Thieme Medical Publishers Inc., 1993, 185.

[12] Ferraris G., Lanza A., Re A., Raspollini M., Proserpio D., Bellino R.: "The significance of lymph node status at pelvic, common ilikeac and para-aortic levels". Baillieres Clin. Obstet. Gynaecol., 1988, 2, 913.

[13] Van de Putte G., Lie A.K., Yach W., Baekelandt M., Kristensen G.B.: "Risk grouping in Stage IB squamous cell cervical carcinoma". Gynecol. Oneal., 2005, 99, 106.

[14] Girardi F., Pickel H., Winter R.: "Pelvic and parametrial lymph nodes in the quality control of the surgical treatment of cervical cancer". Gynecol. Oneal., 1993, 50, 330.

[15] Inoue T., Morita K.: "The prognostic significance of number of positive nodes in cervical carcinoma Stages IB, IIA, and 11B" Cancer, 1990, 65, 1923.

[16] Sevin B-U., Nadji M., Lampe B., Lu Y., Hilsenbeck S., Koechh O.R., Averette H.E.: "Prognostic factors of early stage cervical cancer treated by radical hysterectomy". Cancer, 1995, 76, 1978.

[17] Michel G., Morice P., Castaigne D., Leblanc M., Rey A., Duvillard P.: "Lymphatic spread in Stage lb and II cervical carcinoma: anatomy and surgical implications". Obstet. Gynecol., 1998, 91, 360.